Pfisterer J - Search Results

1

[Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].

du Bois A, Lück HJ, Pfisterer J, Meier W, Bauknecht T. du Bois A, et al. Among authors: pfisterer j. Zentralbl Gynakol. 2000;122(5):255-67. Zentralbl Gynakol. 2000. PMID: 10857212 Review. German.

2

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.

du Bois A, Lück HJ, Pfisterer J, Schroeder W, Blohmer JU, Kimmig R, Moebus V, Quaas J. du Bois A, et al. Among authors: pfisterer j. Ann Oncol. 2001 Aug;12(8):1115-20. doi: 10.1023/a:1011605008922. Ann Oncol. 2001. PMID: 11583193 Free article.

3

Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective.

du Bois A, Pfisterer J, Meier W, Wagner U. du Bois A, et al. Among authors: pfisterer j. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:169-71. doi: 10.1111/j.1525-1438.2003.t01-2-13352.x. Int J Gynecol Cancer. 2003. PMID: 14656275

4

[First-line therapy in ovarian cancer].

du Bois A, Pfisterer J. du Bois A, et al. Among authors: pfisterer j. Zentralbl Gynakol. 2004 Oct;126(5):312-4. doi: 10.1055/s-2004-820390. Zentralbl Gynakol. 2004. PMID: 15478049 Review. German.

5

[The Quality Assurance Program of the AGO Organkommission OVAR (QS-OVAR): Pattern of Care and Reality in Germany 2001].

du Bois A, Rochon J, Lamparter C, Pfisterer J. du Bois A, et al. Among authors: pfisterer j. Zentralbl Gynakol. 2005 Feb;127(1):9-17. doi: 10.1055/s-2005-836289. Zentralbl Gynakol. 2005. PMID: 15702446 German.

6

[Impact of center characteristics on outcome in ovarian cancer in Germany].

du Bois A, Rochon J, Lamparter C, Pfisterer J. du Bois A, et al. Among authors: pfisterer j. Zentralbl Gynakol. 2005 Feb;127(1):18-30. doi: 10.1055/s-2005-836290. Zentralbl Gynakol. 2005. PMID: 15702447 German.

7

Future options for first-line therapy of advanced ovarian cancer.

Du Bois A, Pfisterer J. Du Bois A, et al. Among authors: pfisterer j. Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:42-50. doi: 10.1111/j.1525-1438.2005.15356.x. Int J Gynecol Cancer. 2005. PMID: 15839958 Free article. Review.

8

[Ovarian cancer -- can peritoneal therapy be regarded as new standard?].

du Bois A, Schmalfeldt B, Meier W, Sehouli J, Pfisterer J. du Bois A, et al. Among authors: pfisterer j. Zentralbl Gynakol. 2006 Aug;128(4):202-6. doi: 10.1055/s-2006-933460. Zentralbl Gynakol. 2006. PMID: 16835814 German.

9

[Pharmacotherapy in ovarian carcinoma].

Pfisterer J, Du Bois A. Pfisterer J, et al. MMW Fortschr Med. 2005 Oct 27;147(43):34-6. MMW Fortschr Med. 2005. PMID: 16302419 Review. German.

10

First-line chemotherapy with epirubicin, paclitaxel, and carboplatin for advanced ovarian cancer: a phase I/II study of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.

du Bois A, Lück HJ, Bauknecht T, Meier W, Richter B, Kuhn W, Quaas J, Pfisterer J. du Bois A, et al. Among authors: pfisterer j. J Clin Oncol. 1999 Jan;17(1):46-51. doi: 10.1200/JCO.1999.17.1.46. J Clin Oncol. 1999. PMID: 10458217 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page